Dongsung Pharm (KO:002210) — Market Cap & Net Worth
Market Cap & Net Worth: Dongsung Pharm (002210)
Dongsung Pharm (KO:002210) has a market capitalization of $16.09 Million (₩23.75 Billion) as of May 5, 2026. Listed on the KO stock exchange, this Korea-based company holds position #25660 globally and #1917 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dongsung Pharm's stock price ₩973.00 by its total outstanding shares 24408359 (24.41 Million). Analyse Dongsung Pharm cash conversion from operations to see how efficiently the company converts income to cash.
Dongsung Pharm Market Cap History: 2015 to 2025
Dongsung Pharm's market capitalization history from 2015 to 2025. Data shows change from $81.71 Million to $16.09 Million (-15.25% CAGR).
Dongsung Pharm Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dongsung Pharm's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Dongsung Pharm's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $69.31 Million | $79.72 Billion | -$1.66 Billion | 0.00x | N/A |
| 2017 | $81.88 Million | $82.39 Billion | -$198.26 Million | 0.00x | N/A |
| 2018 | $247.29 Million | $91.91 Billion | -$5.74 Billion | 0.00x | N/A |
| 2019 | $265.49 Million | $86.54 Billion | -$8.39 Billion | 0.00x | N/A |
| 2020 | $205.94 Million | $87.80 Billion | -$14.08 Billion | 0.00x | N/A |
| 2021 | $138.62 Million | $84.41 Billion | -$4.31 Billion | 0.00x | N/A |
| 2022 | $110.50 Million | $93.33 Billion | -$2.12 Billion | 0.00x | N/A |
| 2023 | $95.28 Million | $88.59 Billion | -$2.07 Billion | 0.00x | N/A |
| 2024 | $76.59 Million | $88.45 Billion | -$7.25 Billion | 0.00x | N/A |
Competitor Companies of 002210 by Market Capitalization
Companies near Dongsung Pharm in the global market cap rankings as of May 5, 2026.
Key companies related to Dongsung Pharm by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
Dongsung Pharm Historical Marketcap From 2015 to 2025
Between 2015 and today, Dongsung Pharm's market cap moved from $81.71 Million to $ 16.09 Million, with a yearly change of -15.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₩16.09 Million | -78.98% |
| 2024 | ₩76.59 Million | -19.62% |
| 2023 | ₩95.28 Million | -13.77% |
| 2022 | ₩110.50 Million | -20.29% |
| 2021 | ₩138.62 Million | -32.69% |
| 2020 | ₩205.94 Million | -22.43% |
| 2019 | ₩265.49 Million | +7.36% |
| 2018 | ₩247.29 Million | +202.02% |
| 2017 | ₩81.88 Million | +18.14% |
| 2016 | ₩69.31 Million | -15.18% |
| 2015 | ₩81.71 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Dongsung Pharm was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.09 Million USD |
| MoneyControl | $16.09 Million USD |
| MarketWatch | $16.09 Million USD |
| marketcap.company | $16.09 Million USD |
| Reuters | $16.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dongsung Pharm
Dong Sung Bio Pharm.Co.,Ltd. manufactures and sells pharmaceuticals and cosmetics in South Korea. The company offers over the counter drugs, such as emollient, vitamin supplement, alopecia treatment, antihistamines, liver disease treatment, fire extinguisher solvent, antiviral, eye drops, menopause treatment, sleep inducer, antipyretic, analgesic, anti-inflammatory, vascular reinforcement, broad-… Read more